Accrol Group Board now expects year-on-year revenue growth to be c.25% on FY21

Accrol Group Holdings plc (LON:ACRL), the UK’s leading independent tissue converter, has provided a trading update for the current financial year ending 30 April 2022.

In line with the wider market, pressures on the Group’s raw material supply chains have been considerable with further tightening in recent weeks. Pulp and parent reel production costs have been impacted across the world by energy cost increases, input shortages, and general inflationary pressures. Whilst the Group’s supply chain has shown significant resilience and supply shortages have been managed, considerable cost increases had to be absorbed in the short term. In addition, distribution pressures, notably the availability of HGV drivers, which served to increase costs further, have restricted revenue growth in FY22.

These cost increases are successfully being passed on, albeit there will be a time lag in passing on the full impact, resulting in earnings in FY22 being lower than previously expected. Overall, operational efficiencies and integration synergies, together with the successful passing on of cost increases, will enable the Group to deliver FY22 percentage EBITDA1 margins in line with those achieved in FY21.

The market share recovery of the UK discount retail sector within the hygiene category continues to see slow but steady improvement. The Group is maintaining its discipline of targeting only higher value business and avoiding long-term fixed price agreements, especially in this period of volatility. This continues to ensure that revenue growth is of good quality.

As previously indicated, revenues and earnings for FY22 remain weighted to the second half of the financial year. The Board now expects year-on-year revenue growth to be c.25% on FY21 (FY21: £136.6m) and adjusted EBITDA1 in FY22 to improve by c.20% (FY21: £15.6m).

The short-term external challenges facing the business have no effect on the ongoing execution of the Group’s strategy. The business remains in excellent operational shape with scalable foundations for growth and a strong market position across UK retail. Accrol remains well placed to benefit from the ongoing recovery in volumes in the discount sector and a more stable cost environment, as the full effects of the pandemic and broader supply chain and distribution constraints unwind.

Accrol Group continues to operate within its banking covenants and the Group’s liquidity and cash flow position remain robust with adjusted net debt2 expected to remain in line with current market expectations.

A further update will be provided at the Group’s H1 22 results, which will be announced in mid-January 2022.

1  Adjusted EBITDA is defined as profit before finance costs, tax, depreciation, amortisation, separately disclosed items and share based payments

2  Adjusted net debt excludes operating type leases recognised on balance sheet in accordance with IFRS 16

Click to view all articles for the EPIC: ,
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Accrol Group Holdings plc

More articles like this

Accrol Group

Family days out that are kind to the environment

The summer holidays can be a great time for family days out. From the beach to the park, there are lots of wonderful places to explore and create lasting memories. But what if you could have

Accrol Group

Natures had enough: Our first-ever TV ad campaign!

Accrol Group Holdings plc (LON:ACRL) is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towel, facial tissue and biodegradable wet wipes. The UK soft tissue market is worth £1.6bn with private label products comprising

Accrol Group

UK grocery inflation eases for fourth month

UK grocery price inflation eased for a fourth consecutive month in July, according to data published by Kantar ahead of official inflation figures on Wednesday. The research company found that the annual pace of grocery price

Accrol Group

Shop price inflation is easing

Britain’s biggest retailers have said shop price inflation is easing ahead of a crunch meeting with MPs on Tuesday over the soaring cost of groceries, but warned food prices were continuing to rise at near record

Accrol Group

UK manufacturing recovery continues

The UK manufacturing industry is seeing a continued rebound in activity in the second quarter of the year, easing fears of a significant recession for the sector. This is according to a survey published today by

Accrol Group

UK soft tissue market worth £1.6bn

The UK soft tissue market is worth £1.6bn with private label products comprising circa 50%. Accrol is the leading supplier to the private label market, which is growing at over 8% year on year. The rapid

Accrol Group

Accrol reports strong performance in trading update

UK-based independent tissue converter Accrol Group has reported FY23 results “at least in line” with market expectations and FY24 margins improving in its latest trading update.   For the year to 30 April 2023, the company said

Accrol Group

Accrol donating to Fife’s ‘multibank’

Corporate donors and others are giving toiletries, mattresses, soap and more to a new phenomenon – multibanks – to nourish and clothe the growing army of poor people. Gordon Brown: Corporate donors and others are giving

Accrol Group

UK manufacturing production rebounded in March

The industrial sector activity rebounded in March, the latest UK industrial and manufacturing production data published by Office for National Statistics (ONS) showed on Friday. Manufacturing output arrived at 0.7% MoM in March versus -0.1% expected and

Accrol Group

CFO takes up Accrol Board post

Toilet roll, kitchen roll, facial tissue and wet wipe products business Accrol Group has welcomed its new chief financial officer to the board. Chris joined the business in October 2022, as part of the Board’s succession

Accrol Group

UK service sector sees strongest growth in 12 months

Growth in the UK’s services sector accelerated sharply in April, according to the latest survey data on Thursday, helping to drive growth in the private sector overall amid a slump in manufacturing. The S&P Global/CIPS services

Accrol Group

Accrol Group appoints Chris Welsh as Chief Financial Officer

Accrol Group Holdings plc (LON:ACRL), the UK’s leading independent tissue converter, has announced that Chris Welsh has today joined the Board as Chief Financial Officer. As detailed in the HY23 Results announcement, Chris succeeds Richard Newman,